ASX:DRUG Holdings Information

ASX:DRUG is an equity ETF with a total of 80 individual holdings. The top holdings are Johnson & Johnson stock at 8.42%, Eli Lilly and Company at 8.03%, AbbVie at 6.69%, UnitedHealth Group at 5.72%, and ROCHE HOLDING AG at 4.87%.

Total Holdings

Top 10 Percentage

51.41%

Asset Class

Equity

ETF Category

Health Care

Assets

183.73M

PE Ratio

22.46

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	8.42%	45,548
2	LLY	Eli Lilly and Company	8.03%	9,288
3	ABBV	AbbVie Inc.	6.69%	35,550
4	UNH	UnitedHealth Group Incorporated	5.72%	18,273
5	ROP.SE	ROCHE HOLDING AG	4.87%	16,064
6	MRK	Merck & Co., Inc.	4.08%	43,225
7	NOVN.SE	NOVARTIS AG	3.84%	34,032
8	LON: AZN	AstraZeneca PLC	3.47%	27,583
9	TMO	Thermo Fisher Scientific Inc.	3.33%	8,276
10	AMGN	Amgen Inc.	2.95%	10,727
11	NOVOB.DC	NOVO NORDISK A/S	2.93%	77,125
12	ABT	Abbott Laboratories	2.68%	36,706
13	GILD	Gilead Sciences, Inc.	2.49%	24,678
14	DHR	Danaher Corporation	2.26%	14,915
15	PFE	Pfizer Inc.	2.23%	120,107
16	ISRG	Intuitive Surgical, Inc.	2.22%	7,463
17	BMY	Bristol-Myers Squibb Company	2.06%	45,968
18	SYK	Stryker Corporation	2.00%	8,171
19	LON: GSK	GSK plc	1.76%	90,305
20	MDT	Medtronic plc	1.67%	27,056
21	SAN.FP	SANOFI	1.63%	25,004
22	VRTX	Vertex Pharmaceuticals Incorporated	1.51%	4,194
23	ELV	Elevance Health, Inc.	1.26%	4,576
24	CI	The Cigna Group	1.18%	5,638
25	REGN	Regeneron Pharmaceuticals, Inc.	1.09%	2,171

Showing 25 of 80 holdings

Subscribe to see the full list

Activate Now

As of Jul 16, 2026